Safety and effectiveness of eribulin in Japanese patients with locally advanced or metastatic breast cancer: a post-marketing observational study

Background This large-scale study was conducted to evaluate the safety and effectiveness of eribulin for the treatment of inoperable or recurrent breast cancer in real-world settings in Japan. Methods Between July and December 2011, eligible patients with inoperable or recurrent breast cancer receiv...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Invest New Drugs
Egile Nagusiak: Watanabe, Junichiro, Ito, Yoshinori, Ohsumi, Shozo, Mizutani, Mitsuhiro, Tashiro, Hideya, Sakurai, Kenichi, Takahashi, Masato, Saito, Tsuyoshi, Tsurutani, Junji, Mukai, Hirofumi, Yoshinami, Tetsuhiro, Takao, Shintaro, Yamamoto, Yasuhisa, Matsuoka, Toshiyuki, Iwase, Hirotaka, Iwata, Hiroji, Nakamura, Seigo, Saeki, Toshiaki
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer US 2017
Gaiak:
Phase II Studies
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5694520/
https://ncbi.nlm.nih.gov/pubmed/28660549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-017-0486-4
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak